A carregar...
MVA E2 therapeutic vaccine for marked reduction in likelihood of recurrence of respiratory papillomatosis
BACKGROUND: Recurrent respiratory papillomatosis (RRP) or laryngeal papillomatosis is a disease caused by papillomavirus infection. METHODS: In this phase I/II clinical trial, we evaluated the efficacy of the modified vaccinia Ankara (MVA) E2 virus in the treatment of RRP. Twenty‐nine patients (18 f...
Na minha lista:
| Publicado no: | Head Neck |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6590416/ https://ncbi.nlm.nih.gov/pubmed/30605254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hed.25477 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|